Mavi Farmaceutica S.A. de C.V.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 9.95 Industry: Chemical Manufacturing Available in: English & Spanish Format: PDF Download Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Calle Osa Menor 197, Col. Prado Churubusco
Mexico City; Federal District of Mexico City; Map
Postal Code: 04230

Tel: +52 551084

Company Description
Mavi Farmaceutica was founded in 1953 with the mission to make medicines for human consumption. In 1961 the founding partners of Mavi created a new lab named Laboratorio Euromex to increase the coverage in the manufacture of other pharmaceutical products. In 1984, they acquired Pharmaceutical CorpCorporacin Farmaceutica and started operations with Quimica Fina Farmex dedicated to the production of active pharmaceutical ingredients. Finally in 2007, this group of companies merge under the name of Mavi Farmaceutica with which they currently operates. They have a distribution network covering all regions of the country.
NAICS Industry Classification
Basic Information
Key Executives

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.


company profiles

We have information on both public and private companies across 125 countries.



EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Contact us to learn more about our business solutions.
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.